Advertisement
Advertisement
U.S. markets close in 2 hours 39 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Exact Sciences Corporation (EXAS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
33.47+0.31 (+0.92%)
As of 01:21PM EDT. Market open.
Advertisement

Exact Sciences Corporation

5505 Endeavor Lane
Madison, WI 53719
United States
608 284 5700
https://www.exactsciences.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees6,420

Key Executives

NameTitlePayExercisedYear Born
Mr. Kevin T. ConroyChairman of The Board & CEO2.37M2.44M1966
Mr. Jeffrey T. Elliott CFAExec. VP, CFO & COO904.67kN/A1978
Mr. D. Scott CowardChief Legal Officer847.28k2.59M1965
Mr. Graham P. LidgardEmeritus Chief Science Officer937.04k5M1949
Mr. Everett V. CunninghamChief Commercial Officer1.01MN/A1966
Dr. Jorge A. Garces Ph.D.Chief Science OfficerN/AN/A1972
Mr. Sri KalluriChief Information OfficerN/AN/AN/A
Ms. Megan JonesAssociate Mang. of Investor RelationsN/AN/AN/A
Mr. Tim CaprezChief Compliance Counsel & VPN/AN/AN/A
Mr. Vic ParkerHead of SalesN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Corporate Governance

Exact Sciences Corporation’s ISS Governance QualityScore as of September 1, 2022 is 4. The pillar scores are Audit: 3; Board: 4; Shareholder Rights: 4; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement